Observational Study “Abilify Maintena”

Observed Drugs

Title of the Observational Study

15960N: Nicht-interventionelle Studie (NIS) zur Untersuchung des Effekts von Abilify Maintena® bei Patienten mit Schizophrenie unter Routinebedingungen in Deutschland

Registered on
06/10/2014
Start date
07/01/2014
End date
03/31/2016
Executing company
Anfomed GmbH
Sponsor
Lundbeck GmbH
Number of Docs1
18
Number of Patients2
1000
Payment per Patient3
500.00 €
Fee details
7 Visiten

Background

Independent journalism needs independent funding

Others can write stories. We want to reveal. We are the first investigative newsroom in Germany, which is independent, ad-free, and non-profit.

For us, the core of journalism means uncovering injustice and shortcomings in society. That’s why we investigate corruption in the health system, politicians abusing their power, and an elite that believes that rules are for the others.

To do our job, we need people, who support us. We ask you, too, to become a member and enable the work of 16 investigative journalists at CORRECTIV.

We are convinced that without independent and critical media, democracy fought for and won by our ancestors, cannot survive for long.